All Stories

  1. Nature-derived Alkaloids as a Promising Bioactive Compound in Drug Discovery to Meet Global Leishmania Needs

    Article • Letters in Drug Design & Discovery, January 2024, Bentham Science Publishers

    Iraj Sharifi, Ardavan Abiri

  2. In silico and in vitro potentials of crocin and amphotericin B on Leishmania major: Multiple synergistic mechanisms of actions

    Article • PLoS ONE, September 2023, PLOS

    Iraj Sharifi

  3. Fifty years of struggle to control cutaneous leishmaniasis in the highest endemic county in Iran: A longitudinal observation inferred with interrupted time series model

    Article • PLoS Neglected Tropical Diseases, April 2022, PLOS

    Iraj Sharifi

  4. A novel diagnostic and prognostic approach for unresponsive patients with anthroponotic cutaneous leishmaniasis using artificial neural networks

    Article • PLoS ONE, May 2021, PLOS

    Iraj Sharifi

  5. Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance

    Article • PLoS Neglected Tropical Diseases, January 2021, PLOS

    Iraj Sharifi

  6. Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran

    Article • PLoS Neglected Tropical Diseases, June 2019, PLOS

    Iraj Sharifi

  7. Population Structure ofLeishmania tropicaCausing Anthroponotic Cutaneous Leishmaniasis in Southern Iran by PCR-RFLP of Kinetoplastid DNA

    Article • BioMed Research International, June 2018, Hindawi Publishing Corporation

    gholamreza shokoohi, Iraj Sharifi

  8. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling

    Article • Tropical Medicine & International Health, May 2018, Wiley

    Iraj Sharifi

  9. Geographical distribution and molecular characterization for cutaneous leishmaniasis species by sequencing and phylogenetic analyses of kDNA and ITS1 loci markers in south-eastern Iran

    Article • Pathogens and Global Health, March 2018, Taylor & Francis

    maryam ramezany, Iraj Sharifi, ali mohammadi

  10. Topical treatment of cutaneous leishmaniasis

    Article • Dermatologic Therapy, April 2015, Wiley

    Dr Mehran Karvar, Iraj Sharifi

  11. Anti-leishmanial Activity of Gossypium hirsutum L., Ferula assa-foetida L. and Artemisia aucheri Boiss. Extracts by Colorimetric Assay

    Article • Anti-Infective Agents, August 2014, Bentham Science Publishers

    Iraj Sharifi